Back
IQVIA Holdings, Inc. (IQV)
Life Sciences Tools & ServicesIQV · NEW YORK STOCK EXCHANGE, INC. · USD
New to investing? How to read this page →$203.79
−2.13%Price · 1 year
Loading live analysis…
Loading analysis…
Intrinsic Investor is for education and research only — not financial advice.
Key metrics
EPS
$7.84
ROE
22.5%
Gross margin
33.0%
Debt/Equity
2.55x
Revenue growth
8.4%
IQVIA Holdings, Inc. — company intelligence
Earnings surprises
Q1 2026$2.90 vs $2.85 est+1.9%
Q4 2025$3.42 vs $3.43 est-0.3%
Q3 2025$3.00 vs $3.00 est-0.0%
Q2 2025$2.81 vs $2.80 est+0.4%
Insider activity · 90 days
12 buys0 sellsnet +13,366 shares
Wims Morris LeslieBuy 171 · May 7, 2026
DANHAKL JOHN GBuy 185 · May 7, 2026
Fasano JimBuy 228 · May 7, 2026
Recent SEC filings
8-K — Material event reportJun 11, 2026
8-K — Material event reportJun 4, 2026
8-K — Material event reportJun 3, 2026
Latest news
Here's Why Investors Should Hold IQV Stock in Their Portfolios Now — Yahoo · 1w ago
IQVIA Holdings' Q2 2026 Earnings: What to Expect — Yahoo · 1w ago
Why Is IQVIA (IQV) Stock Soaring Today — Yahoo · 1w ago
Baird Maintains Outperform on IQVIA Holdings, Raises Price Target to $249 — Benzinga · 1w ago
AI Valuation Narrative
Generates a short bull / bear / catalyst summary from the analytics we already computed. No target prices. Research tool, not investment advice.
Explore more
Peers & similar stocks
Quick links to related tickers for research.
About IQVIA Holdings, Inc.
Weekly undervalued picks (like IQV)
Get 3 new value ideas and the fair-value math behind them every week. One email, unsubscribe anytime.
Free. No spam. We only email once per week.
Data is provided "as-is" and may be delayed or incomplete. Intrinsic Investor is for education only and is not investment advice.